Coverage

American Association of Swine Veterinarians: Survey: Addressing Unmet Need Within the Animal and Veterinary Industries
The Reagan-Udall Foundation for the FDA is leading an initiative to identify holistic approaches to address opportunities and challenges in animal health and veterinary medicine.
Read More
Pharmaceutical Technology: FDA Rare Disease Innovation Moves Forward
In establishing the Hub, FDA gathered feedback from stakeholders through a public meeting, held on Oct. 16, 2024 in collaboration with the Reagan-Udall Foundation.
Read More
U.S. Food & Drug Administration: FDA Takes Exciting Steps Toward Establishing the Rare Disease Innovation Hub
In collaboration with the Reagan-Udall Foundation for the FDA, we hosted a public meeting, Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub, on October 16, 2024.
Read More
Benzinga: FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care
Federal agencies recently convened in a pivotal public meeting, hosted by the Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA), to discuss emerging treatments for post-traumatic stress disorder (PTSD), with a focus on the…
Read More
Food Safety News: Transforming FDA-regulated food products: A webinar with Jim Jones
The reorganization had its origins in the Reagan-Udall Foundation report, which was released less than two years ago. The report focused on ways to clarify the mission of the human food program and achieve more urgency in preventing foodborne illnesses.
Read More
Wiley Online Library: The Oncology QCARD Initiative: Fostering efficient evaluation of initial real-world data proposals
The oncology quality, characterization, and assessment of real-world data (Oncology QCARD) Initiative was formed to develop a set of minimum study design and data elements needed to evaluate the fitness of the real-world data (RWD) source(s) proposed in…
Read More
BioCentury: Perspective: A path forward for rare disease policy
The rare disease policy calendar in Washington has been packed. Highlights have included an advisory committee meeting for a Barth syndrome treatment from Stealth BioTherapeutics, a meeting about FDA’s Rare Disease Innovation Hub convened by the Reagan-…
Read More
The Evidence Base: Advancing real-world data research through the Innovation in Medical Evidence and Development Surveillance (IMEDS) program: an interview with Carla Rodriguez-Watson, Reagan-Udall Foundation for the FDA
Advancing real-world data research through the Innovation in Medical Evidence and Development Surveillance (IMEDS) program: an interview with Carla Rodriguez-Watson, Reagan-Udall Foundation for the FDA.
Read More
Food Navigator: Food Traceability Rule compliance threatened by too much tech, over-eager realtors
Food industry players across the value chain are frustrated by lingering questions about how to implement sweeping food safety changes that go into effect in little over a year, including fears of some stakeholders “going berserk” with new technology or…
Read More
Pharmacy Times: Review of 3 Alternative Pathways to Access Non–FDA-Approved Drugs
Recently, the FDA has taken additional actions to clarify and streamline its policies regarding the EA process, including issuing guidance documents on EA, restructuring the FDA web page on EA, launching Project Facilitate (a call and information center…
Read More